Friedman CF - Search Results

1

Treatment of the Immune-Related Adverse Effects of Immune Checkpoint Inhibitors: A Review.

Friedman CF, Proverbs-Singh TA, Postow MA. Friedman CF, et al. JAMA Oncol. 2016 Oct 1;2(10):1346-1353. doi: 10.1001/jamaoncol.2016.1051. JAMA Oncol. 2016. PMID: 27367787 Review.

2

Emerging Tissue and Blood-Based Biomarkers that may Predict Response to Immune Checkpoint Inhibition.

Friedman CF, Postow MA. Friedman CF, et al. Curr Oncol Rep. 2016 Apr;18(4):21. doi: 10.1007/s11912-016-0509-x. Curr Oncol Rep. 2016. PMID: 26922327 Free PMC article. Review.

3

Atypical autoimmune adverse effects with checkpoint blockade therapies.

Friedman CF, Snyder A. Friedman CF, et al. Ann Oncol. 2017 Feb 1;28(2):206-207. doi: 10.1093/annonc/mdw658. Ann Oncol. 2017. PMID: 27993802 Free article. No abstract available.

4

Thinking Critically About Classifying Adverse Events: Incidence of Pancreatitis in Patients Treated With Nivolumab + Ipilimumab.

Friedman CF, Clark V, Raikhel AV, Barz T, Shoushtari AN, Momtaz P, Callahan MK, Wolchok JD, Chapman PB, Hellmann MD, Postow MA. Friedman CF, et al. J Natl Cancer Inst. 2016 Dec 31;109(4):djw260. doi: 10.1093/jnci/djw260. Print 2017 Apr. J Natl Cancer Inst. 2016. PMID: 28040701 Free PMC article.

5

Checkpoint inhibition and melanoma: Considerations in treating the older adult.

Friedman CF, Wolchok JD. Friedman CF, et al. J Geriatr Oncol. 2017 Jul;8(4):237-241. doi: 10.1016/j.jgo.2017.04.003. Epub 2017 May 11. J Geriatr Oncol. 2017. PMID: 28506536 Free PMC article. Review.

6

Measuring Toxic Effects and Time to Treatment Failure for Nivolumab Plus Ipilimumab in Melanoma.

Shoushtari AN, Friedman CF, Navid-Azarbaijani P, Postow MA, Callahan MK, Momtaz P, Panageas KS, Wolchok JD, Chapman PB. Shoushtari AN, et al. Among authors: friedman cf. JAMA Oncol. 2018 Jan 1;4(1):98-101. doi: 10.1001/jamaoncol.2017.2391. JAMA Oncol. 2018. PMID: 28817755 Free PMC article. Clinical Trial.

7

Peripheral blood clinical laboratory variables associated with outcomes following combination nivolumab and ipilimumab immunotherapy in melanoma.

Rosner S, Kwong E, Shoushtari AN, Friedman CF, Betof AS, Brady MS, Coit DG, Callahan MK, Wolchok JD, Chapman PB, Panageas KS, Postow MA. Rosner S, et al. Among authors: friedman cf. Cancer Med. 2018 Mar;7(3):690-697. doi: 10.1002/cam4.1356. Epub 2018 Feb 22. Cancer Med. 2018. PMID: 29468834 Free PMC article.

8

Early disease progression and treatment discontinuation in patients with advanced ovarian cancer receiving immune checkpoint blockade.

Boland JL, Zhou Q, Martin M, Callahan MK, Konner J, O'Cearbhaill RE, Friedman CF, Tew W, Makker V, Grisham RN, Hensley ML, Zecca N, Iasonos AE, Snyder A, Hyman DM, Sabbatini P, Aghajanian C, Cadoo KA, Zamarin D. Boland JL, et al. Among authors: friedman cf. Gynecol Oncol. 2019 Feb;152(2):251-258. doi: 10.1016/j.ygyno.2018.11.025. Epub 2018 Nov 22. Gynecol Oncol. 2019. PMID: 30470581 Free PMC article.

9

Utility of serum CA-125 monitoring in patients with ovarian cancer undergoing immune checkpoint inhibitor therapy.

Boland JL, Zhou Q, Iasonos AE, O'Cearbhaill RE, Konner J, Callahan M, Friedman C, Aghajanian C, Sabbatini P, Zamarin D, Cadoo KA. Boland JL, et al. Gynecol Oncol. 2020 Aug;158(2):303-308. doi: 10.1016/j.ygyno.2020.04.710. Epub 2020 Jun 2. Gynecol Oncol. 2020. PMID: 32507515 Free PMC article.

10

Imaging findings of immune checkpoint inhibitor associated pancreatitis.

Das JP, Postow MA, Friedman CF, Do RK, Halpenny DF. Das JP, et al. Among authors: friedman cf. Eur J Radiol. 2020 Oct;131:109250. doi: 10.1016/j.ejrad.2020.109250. Epub 2020 Aug 29. Eur J Radiol. 2020. PMID: 32905952 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

52 results

Search Page